Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Non-Current Liabilities (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $25.3 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 67.14% to $25.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.3 million through Dec 2025, up 67.14% year-over-year, with the annual reading at $25.3 million for FY2025, 67.14% up from the prior year.
  • Total Non-Current Liabilities hit $25.3 million in Q4 2025 for Camp4 Therapeutics, up from $11.0 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $25.3 million in Q4 2025 to a low of $11.0 million in Q3 2025.
  • Historically, Total Non-Current Liabilities has averaged $15.5 million across 3 years, with a median of $15.2 million in 2024.
  • Biggest YoY gain for Total Non-Current Liabilities was 67.14% in 2025; the steepest drop was 39.55% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $16.5 million in 2023, then fell by 8.25% to $15.2 million in 2024, then skyrocketed by 67.14% to $25.3 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for CAMP at $25.3 million in Q4 2025, $11.0 million in Q3 2025, and $11.3 million in Q2 2025.